case_images: PMC11096580_01
case_images: Hematologic and Organ Response of case 1 and case 2 with SDd. (A) Graphical illustration of M-companies and lambda free light chains during the treatment course of case 1. (B) Illustration of 24-h urine collection, NT-proBNP and hsTnl over time since diagnosis of AL, representative of organ response of case 1. (C) Graphical illustration of M-companies and lambda free light chains during the treatment course of case 2. (D) Illustration of 24-h urine collection, NT-proBNP and hsTnl over time since diagnosis of AL, representative of organ response of case 2.
case_images: fmed-11-1363805-g0001.jpg
case_images: PMC11096580_02_fmed-11-1363805-g0001.jpg
case_images: F1
case_images: A very good hematological partial response (VGPR) was achieved after two cycles of treatment, with dFLC decreased from 236.2 to 39.4 mg/L (Figures 1C, D).
case_images: PMC11096580_02
case_images: Hematologic and Organ Response of case 1 and case 2 with SDd. (A) Graphical illustration of M-companies and lambda free light chains during the treatment course of case 1. (B) Illustration of 24-h urine collection, NT-proBNP and hsTnl over time since diagnosis of AL, representative of organ response of case 1. (C) Graphical illustration of M-companies and lambda free light chains during the treatment course of case 2. (D) Illustration of 24-h urine collection, NT-proBNP and hsTnl over time since diagnosis of AL, representative of organ response of case 2.
case_images: fmed-11-1363805-g0001.jpg
case_images: PMC11096580_02_fmed-11-1363805-g0001.jpg
case_images: F1
case_images: A very good hematological partial response (VGPR) was achieved after two cycles of treatment, with dFLC decreased from 236.2 to 39.4 mg/L (Figures 1C, D).